Aura Biosciences, Inc. (AURA): Submission of Matters to a Vote of Security Holders
Aura Biosciences, Inc. (AURA) filed an SEC Form 8-K — Submission of Matters to a Vote of Security Holders. 8-K false 0001501796 0001501796 2026-06-11 2026-06-11 UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): June 11,
How this was made
The 30-second read
Why it matters
The disclosure confirms the board composition (two Class II directors elected) and ratifies Ernst & Young LLP as independent auditor for FY ending Dec. 31, 2026; it does not introduce new business, financial, or regulatory developments.
Market read
Routine corporate governance outcome; likely limited trading impact absent additional catalysts.
What to watch
Traders may still monitor for follow-on filings (e.g., subsequent 10-K/10-Q updates) rather than the vote outcome itself.
Background
The company’s 8-K Item 5.07 reports matters submitted to stockholders at the 2026 Annual Meeting, referencing the April 20, 2026 definitive proxy statement.
Ticker impact
Aura Biosciences filed an 8-K confirming stockholder votes at its June 11, 2026 annual meeting, including director elections and E&Y ratification.
Low likelihood of a sustained price move; any reaction is likely brief and sentiment/flow-driven.
The filing reports vote tallies and ratification of the auditor, without new financial guidance, transactions, or regulatory/clinical catalysts.
Market effects
Minimal; auditor ratification and director election outcomes are not sector-moving.
None indicated.
None indicated.
Counterpoint
If the vote results were contested or signaled governance instability, it could matter—but the article provides no such context beyond the tallies.
Key entities
- issuerAura Biosciences, Inc.
Nasdaq-listed company filing the 8-K with annual meeting vote results.
- auditorErnst & Young LLP
Ratified by stockholders as independent registered public accounting firm for FY ending Dec. 31, 2026.
- director_nomineeDavid Johnson
Elected as Class II director (votes for/withheld/broker non-votes reported).
- director_nomineeTeresa Marie Bitetti
Elected as Class II director (votes for/withheld/broker non-votes reported).
